NRAS and KRAS variants are the most common accounting for 4.5–8.2% and 4.3–9.1% of ML-DS cases respectively (Yoshida et al., 2013; Labuhn et al., 2019; Panferova et al., 2021). The gene discussed is NRAS; the disease is Dravet syndrome.